Glechoma hederacea inhibits inflammatory mediator release in IFN-γ and LPS-stimulated mouse peritoneal macrophages

Journal of Ethnopharmacology

Volumn 106, Issue 3, 2006, Pages 418-424

  An, Hyo Jin ^a,b   Jeong, Hyun Ja ^a   Um, Jae Young ^a   Kim, Hyung Min ^a   Hong, Seung Heon ^b  

^a Kyung Hee University   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

Glechoma hederacea; Interleukin 12p40; Interleukin 12p70; Mouse peritoneal macrophage; Nitric oxide; Tumor necrosis factor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLECHOMA HEDERACEA EXTRACT; HERBACEOUS AGENT; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; GLECHOMA HEDERACEA; HERB; INFLAMMATION; INHIBITION KINETICS; MEDIATOR RELEASE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; INTERFERON TYPE II; LAMIACEAE; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; NITRIC OXIDE; PHYTOTHERAPY; PLANT EXTRACTS;

GLECHOMA HEDERACEA;

EID: 33745198197     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2006.01.024     Document Type: Article

References (28)

1. Adams D.O., and Hamilton T.A. The cell biology of macrophage activation. Annual Review of Immunology 2 (1984) 283-318
2. Barnes P.J. Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine and Growth Factor Reviews 14 (2003) 511-522
3. Chung H.S., An H.J., Jeong H.J., Won J.H., Hong S.H., and Kim H.M. Water extract isolated from Chelidonium majus enhances nitric oxide and tumour necrosis factor-alpha production via nuclear factor-kappaB activation in mouse peritoneal macrophages. Journal of Pharmacy and Pharmacology 56 (2004) 129-134
4. Chung H.S., Jeong H.J., Hong S.H., Kim M.S., Kim S.J., Song B.K., Jeong I.S., Lee E.J., Ahn J.W., Baek S.H., and Kim H.M. Induction of nitric oxide synthase by Oldenlandia diffusa in mouse peritoneal macrophages. Biological and Pharmaceutical Bulletin 25 (2002) 1142-1146
5. Connelly L., Palacios-Callender M., Ameixa C., Moncada S., and Hobbs A.J. Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. Journal of Immunology 166 (2001) 3873-3881
6. Dinarello C.A. Proinflammatory cytokines. Chest 118 (2000) 503-508
7. Evans C.H. Nitric oxide: what role does it play in inflammation and tissue destruction?. Agents and Actions Supplements 47 (1995) 107-116
8. Gately M.K., Renzetti L.M., Magram J., Stern A.S., Adorini L., Gubler U., and Presky D.H. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annual Review of Immunology 16 (1998) 495-521
9. Gorman J.D., Sack K.E., and Davis Jr. J.C. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. New England Journal of Medicine 346 (2002) 1349-1356
10. Huang F.P., Niedbala W., Wei X.Q., Xu D., Feng G.J., Robinson J.H., Lam C., and Liew F.Y. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. European Journal of Immunology 28 (1998) 4062-4070
11. Jeong H.J., Chung H.S., An H.J., Kim J.B., Lee E.M., Park E.J., Jang C.H., Hong S.H., and Kim H.M. Immune-enhancement effect of the herbal combination Allergina. Clinica Chimica Acta 337 (2003) 77-84
12. Kalinski P., Vieira P.L., Schuitemaker J.H., de Jong E.C., and Kapsenberg M.L. Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 97 (2001) 3466-3469
13. Kumarasamy Y., Cox P.J., Jaspars M., Nahar L., and Sarker S.D. Biological activity of Glechoma hederacea. Fitoterapia 73 (2002) 721-723
14. Mary N.K., Shylesh B.S., Babu B.H., and Padikkala J. Antioxidant and hypolipidaemic activity of a herbal formulation--liposem. Indian Journal of Experimental Biology 40 (2002) 901-904
15. Nathan C. Nitric oxide as a secretory product of mammalian cells. The FASEB Journal 6 (1992) 3051-3064
16. Ohigashi H., Takamura H., Koshimizu K., Tokuda H., and Ito Y. Search for possible antitumor promoters by inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation; ursolic acid and oleanolic acid from an anti-inflammatory Chinese medicinal plant, Glechoma hederaceae L. Cancer Letters 30 (1986) 143-151
17. O'Shea J.J., Ma A., and Lipsky P. Cytokines and autoimmunity. Nature Reviews Immunology 2 (2002) 37-45
18. Petros A., Bennet D., and Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovascular Research 28 (1994) 34-39
19. Punzon C., Alcaide A., and Fresno M. In vitro anti-inflammatory activity of Phlebodium decumanum. Modulation of tumor necrosis factor and soluble TNF receptors. International Immunopharmacology 3 (2003) 1293-1299
20. Schimmer B.P., and Parker K.L. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman J.G., Limbird L.E., and Goodman Gilman A. (Eds). The Pharmacological Basis of Therapeutics. 10th ed. (2001), McGraw-Hill, New York 1649-1677
21. Sharma G., Tyagi A.K., Singh R.P., Chan D.C., and Agarwal R. Synergistic anti-cancer effects of grape seed extract and conventional cytotoxic agent doxorubicin against human breast carcinoma cells. Breast Cancer Research and Treatment 85 (2004) 1-12
22. Thiemermann C., and Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. European Journal of Pharmacology 182 (1990) 591-595
23. Tokuda H., Ohigashi H., Koshimizu K., and Ito Y. Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Letters 33 (1986) 279-285
24. Trikha M., Corringham R., Klein B., and Rossi J.F. Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. Clinical Cancer Research 9 (2003) 4653-4665
25. Trinchieri G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Advances in Immunology 70 (1998) 83-243
26. Wang W., Peumans W.J., Rouge P., Rossi C., Proost P., Chen J., and Van Damme E.J. Leaves of the Lamiaceae species Glechoma hederacea (ground ivy) contain a lectin that is structurally and evolutionary related to the legume lectins. The Plant Journal 33 (2003) 293-304
27. Wei X.Q., Charles I.G., Smith A., Ure J., Feng G.J., Huang F.P., Xu D., Muller W., Moncada S., and Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375 (1995) 408-411
28. Xie Q.W., Cho H.J.J., Mumford R.A., Swiderek K.M., Lee T.D., Ding A., Troso T., and Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256 (1992) 225-228